Trial Profile
A Phase 1, Single-Center, Open-label, Infusion Dose Optimization Study of ABP-700 in Healthy, Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2021
Price :
$35
*
At a glance
- Drugs Cyclopropyl-methoxycarbonylmetomidate (Primary)
- Indications Anaesthesia
- Focus Adverse reactions
- 01 Jan 2021 Results (n=350) from NTR4545, NTR4735, NTR5173, NTR5231, and NTR5442 modeling the effect of excitation on depth of anesthesia in ABP-700, published in the Anesthesiology
- 14 Jun 2016 Status changed from not yet recruiting to completed, according to The Medicines Company media release.
- 14 Aug 2015 New trial record